Search Results - "Pischimarov, J"

The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum by Momose, S, Weißbach, S, Pischimarov, J, Nedeva, T, Bach, E, Rudelius, M, Geissinger, E, Staiger, A M, Ott, G, Rosenwald, A

Get full text

Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing by Zamò, A, Pischimarov, J, Schlesner, M, Rosenstiel, P, Bomben, R, Horn, H, Grieb, T, Nedeva, T, López, C, Haake, A, Richter, J, Trümper, L, Lawerenz, C, Klapper, W, Möller, P, Hummel, M, Lenze, D, Szczepanowski, M, Flossbach, L, Schreder, M, Gattei, V, Ott, G, Siebert, R, Rosenwald, A, Leich, E

“…Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15–~50% of cases. Nevertheless, most of these cases express BCL2. To elucidate…”
Get full text

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules by Leich, E, Weißbach, S, Klein, H-U, Grieb, T, Pischimarov, J, Stühmer, T, Chatterjee, M, Steinbrunn, T, Langer, C, Eilers, M, Knop, S, Einsele, H, Bargou, R, Rosenwald, A

“…Multiple myeloma (MM) is a largely incurable plasma cell malignancy with a poorly understood and heterogeneous clinical course. To identify potential,…”
Get full text

(Germline) mutations in receptor tyrosine kinases: A prognostic marker in multiple myeloma? by Keppler, S, Weißbach, S, Langer, C, Knop, S, Pischimarov, J, Kull, M, Stuehmer, T, Steinbrunn, T, Bargou, R, Einsele, H, Rosenwald, A, Leich, E

Get full text